Cheedy Jaja, MD, at Georgia Health Sciences University is studying how gene variations that play a role in metabolizing opioids could improve pain management for sickle cell disease, according to a news release.
Dr. Jaja will study 100 adult patients at GHSU's Sickle Cell Center in Augusta and satellite clinics in Albany, Macon, Savannah and Valdosta. He will define gene variations that determine how pain medications are metabolized and track emergency department visits and medication prescriptions. He thinks people with a gene that poorly or quickly metabolizes medication will visit the hospital more often.
Related Articles on Pain Management:
Spinal Modulation System Receives CE Mark for the Management of Chronic Intractable Pain
Medical Marijuana Used With Opiates Could Help Patients Reduce Pain
BioLineRx Drug Gets Positive Results in Clinical Trial for Neuropathic Pain
Related Articles on Pain Management:
Spinal Modulation System Receives CE Mark for the Management of Chronic Intractable Pain
Medical Marijuana Used With Opiates Could Help Patients Reduce Pain
BioLineRx Drug Gets Positive Results in Clinical Trial for Neuropathic Pain